Daiichi Sankyo Co Ltd ESMO 2021 Highlights Call Transcript
Thank you for waiting. We are now ready to start Daiichi Sankyo's conference call to present ESMO 2021 highlights. Please note that today's call will be recorded under [management] of today's presentation and Q&A is English. Dr. Takeshita, please go ahead.
Thank you very much for the introduction, and thank you to all of you for joining this call. My name is Ken Takeshita, Global Head of R&D at Daiichi Sankyo. And welcome to our conference call to present our ESMO 2021 highlights. And I'm going to follow the slide deck that you have in front of you.
Slide #2, you got your usual statement and disclaimers. So we'll go on to the Slide #3 and then 4. 3 represents our agenda for today. We'll give you the introduction, followed by highlights and actual ESMO presentation from 3 clinical trials that we would like to highlight. And then, of course, there is a very lengthy appendix we have in front of you at the end.
So Slide #4. We want to emphasize here
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
